In vivo CRO Market Size, Share & Trends Report

In vivo CRO Market Size, Share & Trends Analysis Report By Product Type, By GLP Type, By Indication (Diabetes, Obesity, Autoimmune/Inflammatory, CNS Conditions), And Segment Forecasts, 2019 - 2026

  • Published Date: Mar, 2019
  • Base Year for Estimate: 2018
  • Report ID: GVR-1-68038-011-8
  • Format: Electronic (PDF)
  • Historical Data: 2015 - 2017
  • Number of Pages: 170

Table of Contents

Chapter 1 Report Scope
                  1.1 Segment Market Scope
                  1.2 Regional Scope
Chapter 2 Methodology
                  2.1 Research Methodology
                      2.1.1 Information Procurement
                  2.2 Information Or Data Analysis
                  2.3 Market Formulation & Validation
                  2.4 Region Wise Market Calculation
                      2.4.1 Region Wise Market: Base Estimates
                      2.4.2 Global Market: CAGR Calculation
                  2.5 Region Based Segment Share Calculation
                  2.6 Model Details
                      2.6.1 Commodity Flow Analysis (Model 1)
                      2.6.2 Volume Price Analysis (Model 2)
                  2.7 List Of Secondary Sources
                  2.8 List Of Primary Sources
                  2.9 List Of Abbreviations
Chapter 3 Objectives
                  3.1 Objective - 1:
                  3.2 Objective - 2:
                  3.3 Objective - 3:
                  3.4 Objective - 4:
Chapter 4 Executive Summary
                  4.1 Market Outlook
                  4.2 Segment Outlook
                  4.3 Competitive Insights
Chapter 5 In Vivo CRO Market: Variables, Trends & Scope
                  5.1 Market Lineage Outlook
                      5.1.1 Parent Market Outlook
                      5.1.2 Ancillary Market Outlook
                  5.2 Penetration & Growth Prospect Mapping
                  5.3 Product Pipeline Analysis, By Stage
                  5.4 User Perspective Analysis
                      5.4.1 Consumer Behavior Analysis
                      5.4.2 Market Influencer Analysis
                  5.5 List Of Key End-Users, By Region / By Product / By Country
                  5.6 Regulatory Framework
                      5.6.1 Reimbursement Framework
                      5.6.2 Standards & Compliances
                  5.7 Market Variable Analysis
                      5.7.1 Market Driver Analysis
                          5.7.1.1 Changing Regulatory Landscape
                          5.7.1.2 Increase In Offshoring Medical Device Manufacturing To Emerging Countries
                          5.7.1.3 Rising Demand For Advanced Products
                          5.7.1.4 Implementation Of International Standards By Contract Manufacturers
                          5.7.1.5 Rising Price Competition And Requirement To Reduce Cost
                          5.7.1.6 Increasing Complexity With Respect To Product Design And Engineering
                      5.7.2 Market Restraint Analysis
                          5.7.2.1 Compliance Issues While Outsourcing
                          5.7.2.2 Changing Scenarios In Developing Countries
                          5.7.2.3 Regulatory And Legal Compliance
                          5.7.2.4 Contractual Obligation
                      5.7.3 Industry Challenges
                  5.8 In Vivo CRO Market: Analysis Tools
                      5.8.1 Porter’s Five Forces Analysis
                      5.8.2 Pestel Analysis
                      5.8.3 Major Deals & Strategic Alliances Analysis
                          5.8.3.1 Joint Ventures
                          5.8.3.2 Mergers & Acquisitions
                          5.8.3.3 Licensing & Partnership
                          5.8.3.4 Technology Collaborations
                          5.8.3.5 Strategic Divestments
                      5.8.4 Market Entry Strategies
Chapter 6 In Vivo CRO Market: Services Segment Analysis
                  6.1 In Vivo CRO Market: Definition & Scope
                  6.2 In Vivo CRO Market: Segment Dashboard
                  6.3 In Vivo CRO Market: Market Share Analysis, 2018 & 2026
                  6.4 Rodent Based In Vivo GLP Type
                      6.4.1 Rodent Based In Vivo GLP Type Market, 2014 - 2026 (USD Billion)
                      6.4.2 Rats Based In Vivo CRO
                          6.4.2.1 Rats Based In Vivo CRO Market, 2014 - 2026 (USD Billion)
                      6.4.3 Mice Based In Vivo CRO
                          6.4.3.1 Mice Based In Vivo CRO Market, 2014 - 2026 (USD Billion)
                      6.4.4 Others
                          6.4.4.1 Others Market, 2014 - 2026 (USD Billion)
                  6.5 Non-Rodent Based In Vivo GLP Type
                      6.5.1 Non-Rodent Based In Vivo GLP Type Market, 2014 - 2026 (USD Billion)
                      6.5.2 Hamsters Based In Vivo CRO
                          6.5.2.1 Hamsters Based In Vivo CRO Market, 2014 - 2026 (USD Billion)
                      6.5.3 Guinea Pigs Based In Vivo CRO
                          6.5.3.1 Guinea Pigs Based In Vivo CRO Market, 2014 - 2026 (USD Billion)
                      6.5.4 Gerbils Based In Vivo CRO
                          6.5.4.1 Gerbils Based In Vivo CRO Market, 2014 - 2026 (USD Billion)
                      6.5.5 Others Based In Vivo CRO
                          6.5.5.1 Others Based In Vivo CRO Market, 2014 - 2026 (USD Billion)
Chapter 7 In Vivo CRO Market: Type Segment Analysis
                  7.1 In Vivo CRO Market: Definition & Scope
                  7.2 In Vivo CRO Market: Segment Dashboard
                  7.3 In Vivo CRO Market: Market Share Analysis, 2018 & 2026
                  7.4 Non GLP
                      7.4.1 Non GLP Market, 2014 - 2026 (USD Billion)
                      7.4.2 In House
                          7.4.2.1 In House Market, 2014 - 2026 (USD Billion)
                      7.4.3 Outsourcing
                          7.4.3.1 Outsourcing Market, 2014 - 2026 (USD Billion)
                  7.5 GLP Toxicology
                      7.5.1 GLP Toxicology Market, 2014 - 2026 (USD Billion)
                      7.5.2 In House
                          7.5.2.1 In House Market, 2014 - 2026 (USD Billion)
                      7.5.3 Outsourcing
                          7.5.3.1 Outsourcing Market, 2014 - 2026 (USD Billion)
Chapter 8 In Vivo CRO Market: Indication Segment Analysis
                  8.1 In Vivo CRO Market: Definition & Scope
                  8.2 In Vivo CRO Market: Segment Dashboard
                  8.3 In Vivo CRO Market: Market Share Analysis, 2018 & 2026
                  8.4 Autoimmune/ Inflammatory Conditions
                      8.4.1 Autoimmune/ Inflammatory Conditions Market, 2014 - 2026 (USD Billion)
                      8.4.2 Rheumatoid Arthritis
                          8.4.2.1 Rheumatoid Arthritis Market, 2014 - 2026 (USD Billion)
                      8.4.3 Multiple Sclerosis
                          8.4.3.1 Multiple Sclerosis Market, 2014 - 2026 (USD Billion)
                      8.4.4 Osteoarthritis
                          8.4.4.1 Osteoarthritis Market, 2014 - 2026 (USD Billion)
                      8.4.5 Irritable Bowel Syndrome
                          8.4.5.1 Irritable Bowel Syndrome Market, 2014 - 2026 (USD Billion)
                      8.4.6 Others
                          8.4.6.1 Others Market, 2014 - 2026 (USD Billion)
                  8.5 Pain Management
                      8.5.1 Pain Management Market, 2014 - 2026 (USD Billion)
                      8.5.2 Chronic Pain
                          8.5.2.1 Chronic Pain Market, 2014 - 2026 (USD Billion)
                      8.5.3 Acute Pain
                          8.5.3.1 Acute Pain Market, 2014 - 2026 (USD Billion)
                  8.6 Oncology
                      8.6.1 Oncology Market, 2014 - 2026 (USD Billion)
                      8.6.2 Blood Cancer
                          8.6.2.1 Blood Cancer Market, 2014 - 2026 (USD Billion)
                      8.6.3 Solid Tumor
                          8.6.3.1 Solid Tumor Market, 2014 - 2026 (USD Billion)
                          8.6.3.2 Syngeneic Model
                              8.6.3.2.1 Syngeneic Model Market, 2014 - 2026 (USD Billion)
                          8.6.3.3 Patient Derived Xenograft
                              8.6.3.3.1 Patient Derived Xenograft Market, 2014 - 2026 (USD Billion)
                          8.6.3.4 Xenograft
                              8.6.3.4.1 Xenograft Market, 2014 - 2026 (USD Billion)
                      8.6.4 Others
                          8.6.4.1 Others Market, 2014 - 2026 (USD Billion)
                  8.7 CNS Conditions
                      8.7.1 CNS Conditions Market, 2014 - 2026 (USD Billion)
                      8.7.2 Epilepsy
                          8.7.2.1 Epilepsy Market, 2014 - 2026 (USD Billion)
                      8.7.3 Parkinson’s Disease
                          8.7.3.1 Parkinson’s Disease Market, 2014 - 2026 (USD Billion)
                      8.7.4 Huntington’s Disease
                          8.7.4.1 Huntington’s Disease Market, 2014 - 2026 (USD Billion)
                      8.7.5 Stroke
                          8.7.5.1 Stroke Market, 2014 - 2026 (USD Billion)
                      8.7.6 Traumatic Brain Injury
                          8.7.6.1 Traumatic Brain Injury Market, 2014 - 2026 (USD Billion)
                      8.7.7 ALS
                          8.7.7.1 ALS Market, 2014 - 2026 (USD Billion)
                      8.7.8 Muscle Regeneration
                          8.7.8.1 Muscle Regeneration Market, 2014 - 2026 (USD Billion)
                      8.7.9 Others
                          8.7.9.1 Others Market, 2014 - 2026 (USD Billion)
                  8.8 Diabetes
                      8.8.1 Diabetes Market, 2014 - 2026 (USD Billion)
                  8.9 Obesity
                      8.9.1 Obesity Market, 2014 - 2026 (USD Billion)
                  8.10 Others
                      8.10.1 Others Market, 2014 - 2026 (USD Billion)
Chapter 9 In Vivo CRO Market: Regional Analysis
                  9.1 In Vivo CRO Market: Definition & Scope
                  9.2 Regional Market Snapshot
                  9.3 Regional Market Share And Leading Players, 2018
                      9.3.1 North America
                      9.3.2 Europe
                      9.3.3 Asia Pacific
                      9.3.4 Latin America
                      9.3.5 Middle East & Africa
                  9.4 SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
                      9.4.1 North America
                      9.4.2 Europe
                      9.4.3 Asia Pacific
                      9.4.4 Latin America
                      9.4.5 Middle East & Africa
                  9.5 In Vivo CRO Market: Market Share Analysis, 2018 & 2026
                  9.6 North America
                      9.6.1 North America In Vivo CRO Market, 2014 - 2026 (USD Billion)
                      9.6.2 U.S.
                          9.6.2.1 U.S. In Vivo CRO Market, 2014 - 2026 (USD Billion)
                      9.6.3 Canada
                          9.6.3.1 Canada In Vivo CRO Market, 2014 - 2026 (USD Billion)
                  9.7 Europe
                      9.7.1 Europe In Vivo CRO Market, 2014 - 2026 (USD Billion)
                      9.7.2 France
                          9.7.2.1 France In Vivo CRO Market, 2014 - 2026 (USD Billion)
                      9.7.3 U.K.
                          9.7.3.1 U.K. In Vivo CRO Market, 2014 - 2026 (USD Billion)
                      9.7.4 Germany
                          9.7.4.1 Germany In Vivo CRO Market, 2014 - 2026 (USD Billion)
                      9.7.5 Italy
                          9.7.5.1 Italy In Vivo CRO Market, 2014 - 2026 (USD Billion)
                      9.7.6 Spain
                          9.7.6.1 Spain In Vivo CRO Market, 2014 - 2026 (USD Billion)
                  9.8 Asia Pacific
                      9.8.1 Asia Pacific In Vivo CRO Market, 2014 - 2026 (USD Billion)
                      9.8.2 Japan
                          9.8.2.1 Japan In Vivo CRO Market, 2014 - 2026 (USD Billion)
                      9.8.3 China
                          9.8.3.1 China In Vivo CRO Market, 2014 - 2026 (USD Billion)
                      9.8.4 India
                          9.8.4.1 India In Vivo CRO Market, 2014 - 2026 (USD Billion)
                      9.8.5 Australia
                          9.8.5.1 Australia In Vivo CRO Market, 2014 - 2026 (USD Billion)
                      9.8.6 South Korea
                          9.8.6.1 South Korea In Vivo CRO Market, 2014 - 2026 (USD Billion)
                  9.9 Latin America
                      9.9.1 Latin America In Vivo CRO Market, 2014 - 2026 (USD Billion)
                      9.9.2 Brazil
                          9.9.2.1 Brazil In Vivo CRO Market, 2014 - 2026 (USD Billion)
                      9.9.3 Mexico
                          9.9.3.1 Mexico In Vivo CRO Market, 2014 - 2026 (USD Billion)
                      9.9.4 Argentina
                          9.9.4.1 Argentina In Vivo CRO Market, 2014 - 2026 (USD Billion)
                      9.9.5 Colombia
                          9.9.5.1 Colombia In Vivo CRO Market, 2014 - 2026 (USD Billion)
                  9.10 MEA
                      9.10.1 MEA In Vivo CRO Market, 2014 - 2026 (USD Billion)
                      9.10.2 South Africa
                          9.10.2.1 South Africa In Vivo CRO Market, 2014 - 2026 (USD Billion)
                      9.10.3 Saudi Arabia
                          9.10.3.1 Saudi Arabia In Vivo CRO Market, 2014 - 2026 (USD Billion)
                      9.10.4 UAE
                          9.10.4.1 UAE In Vivo CRO Market, 2014 - 2026 (USD Billion)
Chapter 10 Competitive Analysis
                  10.1 Recent Developments & Impact Analysis, By Key Market Participants
                  10.2 Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
                  10.3 Vendor Landscape
                      10.3.1 List Of Key Distributors And Channel Partners
                      10.3.2 Key Customers
                      10.3.3 Key Company Market Share Analysis, 2018
                  10.4 Public Companies
                      10.4.1 Company Market Position Analysis (Revenue, Geographic Presence, Product Portfolio, Key Serviceable Industries, Key Alliances)
                      10.4.2 Company Market Share/Ranking, By Region
                      10.4.3 Competitive Dashboard Analysis
                          10.4.3.1 Market Differentiators
                          10.4.3.2 Synergy Analysis: Major Deals & Strategic Alliances
                  10.5 Private Companies
                      10.5.1 List Of Key Emerging Companies’ /Technology Disruptors/Innovators
                      10.5.2 Funding Outlook (Optional)
                      10.5.3 Regional Network Map
                      10.5.4 Company Market Position Analysis (Geographic Presence, Product Portfolio, Key Alliance, Industry Experience)
                  10.6 Supplier Ranking
Chapter 11 Company Profiles
                  11.1 Strategic Framework
                      11.1.1 QUINTILES
                          11.1.1.1 Company Overview
                          11.1.1.2 Financial Performance
                          11.1.1.3 Service Benchmarking
                          11.1.1.4 Strategic Initiatives
                      11.1.2 CHARLES RIVER LABORATORIES
                          11.1.2.1 Company Overview
                          11.1.2.2 Financial Performance
                          11.1.2.3 Service Benchmarking
                      11.1.3 ICON PLC
                          11.1.3.1 Company Overview
                          11.1.3.2 Financial Performance
                          11.1.3.3 Service Benchmarking
                          11.1.3.4 Strategic Initiatives
                      11.1.4 COVANCE INC.
                          11.1.4.1 Company Overview
                          11.1.4.2 Financial Performance
                          11.1.4.3 Service Benchmarking
                          11.1.4.4 Strategic Initiatives
                      11.1.5 PAREXEL INTERNATIONAL
                          11.1.5.1 Company Overview
                          11.1.5.2 Financial Performance
                          11.1.5.3 Service Benchmarking
                          11.1.5.4 Strategic Initiatives
                      11.1.6 PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC (PPD)
                          11.1.6.1 Company Overview
                          11.1.6.2 Financial Performance
                          11.1.6.3 Service Benchmarking
                          11.1.6.4 Strategic Initiatives
                      11.1.7 THEOREM CLINICAL RESEARCH
                          11.1.7.1 Company Overview
                          11.1.7.2 Financial Performance
                          11.1.7.3 Service Benchmarking
                          11.1.7.4 Strategic Initiatives
                      11.1.8 INVENTIV HEALTH
                          11.1.8.1 Company Overview
                          11.1.8.2 Financial Performance
                          11.1.8.3 Service Benchmarking
                      11.1.9 WUXI APPTEC, INC.
                          11.1.9.1 Company Overview
                          11.1.9.2 Financial Performance
                          11.1.9.3 Service Benchmarking
                          11.1.9.4 Strategic Initiatives
                      11.1.10 AMERICAN PRECLINICAL SERVICES, LLC.
                          11.1.10.1 Company Overview
                          11.1.10.2 Service Benchmarking
                          11.1.10.3 Strategic Initiatives
                      11.1.11 EVOTEC (US), INC.
                          11.1.11.1 Company Overview
                          11.1.11.2 Financial Performance
                          11.1.11.3 Service Benchmarking
                          11.1.11.4 Strategic Initiatives
Chapter 12 KOL Commentary
Chapter 13 Recommendations


List of Tables

Table 1 List of secondary sources
Table 2 List of Abbreviation
Table 3 Leading market players anticipated to witness highest growth
Table 5 Global In vivo CRO Market Estimates & Forecasts, by Region, 2014 - 2026 (USD Million)
Table 6 Global In vivo GLP type CRO Market, by Country 2015 - 2026 (USD Million)
Table 7 Global In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
Table 8 Global Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 9 Global Non-rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 10 Global In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 11 Global Autoimmune Conditions based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 12 Global Pain management based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 13 Global Oncology based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 14 Global Solid Tumor based In vivo CRO Market, by Model, 2015 - 2026 (USD Million)
Table 15 Global CNS based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 16 Global In vivo CRO Market, by GLP Type 2015 - 2026 (USD Million)
Table 17 Global GLP Toxicology based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 18 Global Non-GLP based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 19 Global Rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 20 Global Rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 21 Global Non-rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 22 Global Non-rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 23 North America In vivo CRO Market Estimates & Forecasts, by Country, 2014 - 2026 (USD Million)
Table 24 North America In vivo GLP type CRO Market, by Country 2015 - 2026 (USD Million)
Table 25 North America In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
Table 26 North America Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 27 North America Non-rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 28 North America In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 29 North America Autoimmune Conditions based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 30 North America Pain management based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 31 North America Oncology based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 32 North America Solid Tumor based In vivo CRO Market, by Model, 2015 - 2026 (USD Million)
Table 33 North America CNS based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 34 North America In vivo CRO Market, by GLP Type 2015 - 2026 (USD Million)
Table 35 North America GLP Toxicology based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 36 North America Non-GLP based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 37 North America Rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 38 North America Rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 39 North America Non-rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 40 North America Non-rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 41 U.S. In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
Table 42 U.S. Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 43 U.S. Non-rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 44 U.S. In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 45 U.S. Autoimmune Conditions based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 46 U.S. Pain management based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 47 U.S. Oncology based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 48 U.S. Solid Tumor based In vivo CRO Market, by Model, 2015 - 2026 (USD Million)
Table 49 U.S. CNS based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 50 U.S. In vivo CRO Market, by GLP Type 2015 - 2026 (USD Million)
Table 51 U.S. GLP Toxicology based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 52 U.S. Non-GLP based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 53 U.S. Rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 54 U.S. Rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 55 U.S. Non-rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 56 U.S. Non-rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 57 Canada In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
Table 58 Canada Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 59 Canada Non-rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 60 Canada In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 61 Canada Autoimmune Conditions based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 62 Canada Pain management based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 63 Canada Oncology based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 64 Canada Solid Tumor based In vivo CRO Market, by Model, 2015 - 2026 (USD Million)
Table 65 Canada CNS based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 66 Canada In vivo CRO Market, by GLP Type 2015 - 2026 (USD Million)
Table 67 Canada GLP Toxicology based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 68 Canada Non-GLP based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 69 Canada Rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 70 Canada Rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 71 Canada Non-rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 72 Canada Non-rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 73 Europe In vivo CRO Market Estimates & Forecasts, by Country, 2014 - 2026 (USD Million)
Table 74 Europe In vivo GLP type CRO Market, by Country 2015 - 2026 (USD Million)
Table 75 Europe In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
Table 76 Europe Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 77 Europe Non-rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 78 Europe In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 79 Europe Autoimmune Conditions based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 80 Europe Pain management based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 81 Europe Oncology based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 82 Europe Solid Tumor based In vivo CRO Market, by Model, 2015 - 2026 (USD Million)
Table 83 Europe CNS based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 84 Europe In vivo CRO Market, by GLP Type 2015 - 2026 (USD Million)
Table 85 Europe GLP Toxicology based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 86 Europe Non-GLP based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 87 Europe Rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 88 Europe Rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 89 Europe Non-rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 90 Europe Non-rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 91 U.K. In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
Table 92 U.K. Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 93 U.K. Non-rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 94 U.K. In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 95 U.K. Autoimmune Conditions based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 96 U.K. Pain management based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 97 U.K. Oncology based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 98 U.K. Solid Tumor based In vivo CRO Market, by Model, 2015 - 2026 (USD Million)
Table 99 U.K. CNS based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 100 U.K. In vivo CRO Market, by GLP Type 2015 - 2026 (USD Million)
Table 101 U.K. GLP Toxicology based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 102 U.K. Non-GLP based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 103 Germany In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
Table 104 Germany Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 105 Germany Non-rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 106 Germany In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 107 Germany Autoimmune Conditions based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 108 Germany Pain management based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 109 Germany Oncology based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 110 Germany Solid Tumor based In vivo CRO Market, by Model, 2015 - 2026 (USD Million)
Table 111 Germany CNS based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 112 Germany In vivo CRO Market, by GLP Type 2015 - 2026 (USD Million)
Table 113 Germany GLP Toxicology based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 114 Germany Non-GLP based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 115 Germany Rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 116 Germany Rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 117 Germany Non-rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 118 Germany Non-rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 119 France In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
Table 120 France Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 121 France Non-rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 122 France In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 123 France Autoimmune Conditions based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 124 France Pain management based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 125 France Oncology based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 126 France Solid Tumor based In vivo CRO Market, by Model, 2015 - 2026 (USD Million)
Table 127 France CNS based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 128 France In vivo CRO Market, by GLP Type 2015 - 2026 (USD Million)
Table 129 France GLP Toxicology based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 130 France Non-GLP based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 131 France Rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 132 France Rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 133 France Non-rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 134 France Non-rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 135 Italy In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
Table 136 Italy Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 137 Italy Non-rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 138 Italy In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 139 Italy Autoimmune Conditions based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 140 Italy Pain management based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 141 Italy Oncology based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 142 Italy Solid Tumor based In vivo CRO Market, by Model, 2015 - 2026 (USD Million)
Table 143 Italy CNS based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 144 Italy In vivo CRO Market, by GLP Type 2015 - 2026 (USD Million)
Table 145 Italy GLP Toxicology based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 146 Italy Non-GLP based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 147 Italy Rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 148 Italy Rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 149 Italy Non-rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 150 Italy Non-rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 151 Spain In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
Table 152 Spain Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 153 Spain Non-rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 154 Spain In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 155 Spain Autoimmune Conditions based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 156 Spain Pain management based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 157 Spain Oncology based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 158 Spain Solid Tumor based In vivo CRO Market, by Model, 2015 - 2026 (USD Million)
Table 159 Spain CNS based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 160 Spain In vivo CRO Market, by GLP Type 2015 - 2026 (USD Million)
Table 161 Spain GLP Toxicology based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 162 Spain Non-GLP based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 163 Spain Rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 164 Spain Rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 165 Spain Non-rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 166 Spain Non-rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 167 RoE In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
Table 168 RoE Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 169 RoE Non-rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 170 RoE In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 171 RoE Autoimmune Conditions based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 172 RoE Pain management based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 173 RoE Oncology based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 174 RoE Solid Tumor based In vivo CRO Market, by Model, 2015 - 2026 (USD Million)
Table 175 RoE CNS based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 176 RoE In vivo CRO Market, by GLP Type 2015 - 2026 (USD Million)
Table 177 RoE GLP Toxicology based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 178 RoE Non-GLP based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 179 RoE Rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 180 RoE Rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 181 RoE Non-rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 182 RoE Non-rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 183 Asia Pacific In vivo CRO Market Estimates & Forecasts, by Country, 2014 - 2026 (USD Million)
Table 184 Asia Pacific In vivo GLP type CRO Market, by Country 2015 - 2026 (USD Million)
Table 185 Asia Pacific In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
Table 186 Asia Pacific Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 187 Asia Pacific Non-rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 188 Asia Pacific In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 189 Asia Pacific Autoimmune Conditions based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 190 Asia Pacific Pain management based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 191 Asia Pacific Oncology based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 192 Asia Pacific Solid Tumor based In vivo CRO Market, by Model, 2015 - 2026 (USD Million)
Table 193 Asia Pacific CNS based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 194 Asia Pacific In vivo CRO Market, by GLP Type 2015 - 2026 (USD Million)
Table 195 Asia Pacific GLP Toxicology based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 196 Asia Pacific Non-GLP based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 197 Asia Pacific Rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 198 Asia Pacific Rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 199 Asia Pacific Non-rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 200 Asia Pacific Non-rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 201 Japan In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
Table 202 Japan Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 203 Japan Non-rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 204 Japan In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 205 Japan Autoimmune Conditions based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 206 Japan Pain management based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 207 Japan Oncology based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 208 Japan Solid Tumor based In vivo CRO Market, by Model, 2015 - 2026 (USD Million)
Table 209 Japan CNS based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 210 Japan In vivo CRO Market, by GLP Type 2015 - 2026 (USD Million)
Table 211 Japan GLP Toxicology based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 212 Japan Non-GLP based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 213 Japan Rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 214 Japan Rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 215 Japan Non-rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 216 Japan Non-rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 217 China In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
Table 218 China Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 219 China Non-rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 220 China In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 221 China Autoimmune Conditions based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 222 China Pain management based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 223 China Oncology based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 224 China Solid Tumor based In vivo CRO Market, by Model, 2015 - 2026 (USD Million)
Table 225 China CNS based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 226 China In vivo CRO Market, by GLP Type 2015 - 2026 (USD Million)
Table 227 China GLP Toxicology based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 228 China Non-GLP based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 229 China Rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 230 China Rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 231 China Non-rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 232 China Non-rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 233 India In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
Table 234 India Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 235 India Non-rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 236 India In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 237 India Autoimmune Conditions based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 238 India Pain management based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 239 India Oncology based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 240 India Solid Tumor based In vivo CRO Market, by Model, 2015 - 2026 (USD Million)
Table 241 India CNS based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 242 India In vivo CRO Market, by GLP Type 2015 - 2026 (USD Million)
Table 243 India GLP Toxicology based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 244 India Non-GLP based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 245 India Rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 246 India Rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 247 India Non-rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 248 India Non-rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 249 South Korea In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
Table 250 South Korea Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 251 South Korea Non-rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 252 South Korea In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 253 South Korea Autoimmune Conditions based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 254 South Korea Pain management based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 255 South Korea Oncology based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 256 South Korea Solid Tumor based In vivo CRO Market, by Model, 2015 - 2026 (USD Million)
Table 257 South Korea CNS based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 258 South Korea In vivo CRO Market, by GLP Type 2015 - 2026 (USD Million)
Table 259 South Korea GLP Toxicology based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 260 South Korea Non-GLP based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 261 South Korea Rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 262 South Korea Rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 263 South Korea Non-rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 264 South Korea Non-rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 265 Australia In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
Table 266 Australia Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 267 Australia Non-rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 268 Australia In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 269 Australia Autoimmune Conditions based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 270 Australia Pain management based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 271 Australia Oncology based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 272 Australia Solid Tumor based In vivo CRO Market, by Model, 2015 - 2026 (USD Million)
Table 273 Australia CNS based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 274 Australia In vivo CRO Market, by GLP Type 2015 - 2026 (USD Million)
Table 275 Australia GLP Toxicology based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 276 Australia Non-GLP based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 277 Australia Rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 278 Australia Rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 279 Australia Non-rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 280 Australia Non-rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 281 RoAPAC In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
Table 282 RoAPAC Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 283 RoAPAC Non-rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 284 RoAPAC In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 285 RoAPAC Autoimmune Conditions based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 286 RoAPAC Pain management based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 287 RoAPAC Oncology based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 288 RoAPAC Solid Tumor based In vivo CRO Market, by Model, 2015 - 2026 (USD Million)
Table 289 RoAPAC CNS based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 290 RoAPAC In vivo CRO Market, by GLP Type 2015 - 2026 (USD Million)
Table 291 RoAPAC GLP Toxicology based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 292 RoAPAC Non-GLP based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 293 RoAPAC Rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 294 RoAPAC Rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 295 RoAPAC Non-rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 296 RoAPAC Non-rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 297 Latin America In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
Table 298 Latin America Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 299 Latin America Non-rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 300 Latin America In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 301 Latin America Autoimmune Conditions based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 302 Latin America Pain management based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 303 Latin America Oncology based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 304 Latin America Solid Tumor based In vivo CRO Market, by Model, 2015 - 2026 (USD Million)
Table 305 Latin America CNS based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 306 Latin America In vivo CRO Market, by GLP Type 2015 - 2026 (USD Million)
Table 307 Latin America GLP Toxicology based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 308 Latin America Non-GLP based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 309 Latin America Rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 310 Latin America Rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 311 Latin America Non-rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 312 Latin America Non-rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 313 Brazil In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
Table 314 Brazil Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 315 Brazil Non-rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 316 Brazil In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 317 Brazil Autoimmune Conditions based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 318 Brazil Pain management based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 319 Brazil Oncology based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 320 Brazil Solid Tumor based In vivo CRO Market, by Model, 2015 - 2026 (USD Million)
Table 321 Brazil CNS based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 322 Brazil In vivo CRO Market, by GLP Type 2015 - 2026 (USD Million)
Table 323 Brazil GLP Toxicology based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 324 Brazil Non-GLP based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 325 Brazil Rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 326 Brazil Rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 327 Brazil Non-rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 328 Brazil Non-rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 329 Mexico In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
Table 330 Mexico Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 331 Mexico Non-rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 332 Mexico In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 333 Mexico Autoimmune Conditions based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 334 Mexico Pain management based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 335 Mexico Oncology based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 336 Mexico Solid Tumor based In vivo CRO Market, by Model, 2015 - 2026 (USD Million)
Table 337 Mexico CNS based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 338 Mexico In vivo CRO Market, by GLP Type 2015 - 2026 (USD Million)
Table 339 Mexico GLP Toxicology based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 340 Mexico Non-GLP based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 341 Mexico Rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 342 Mexico Rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 343 Mexico Non-rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 344 Mexico Non-rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 345 Colombia In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
Table 346 Colombia Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 347 Colombia Non-rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 348 Colombia In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 349 Colombia Autoimmune Conditions based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 350 Colombia Pain management based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 351 Colombia Oncology based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 352 Colombia Solid Tumor based In vivo CRO Market, by Model, 2015 - 2026 (USD Million)
Table 353 Colombia CNS based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 354 Colombia In vivo CRO Market, by GLP Type 2015 - 2026 (USD Million)
Table 355 Colombia GLP Toxicology based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 356 Colombia Non-GLP based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 357 Colombia Rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 358 Colombia Rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 359 Colombia Non-rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 360 Colombia Non-rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 361 RoLA In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
Table 362 RoLA Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 363 RoLA Non-rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 364 RoLA In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 365 RoLA Autoimmune Conditions based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 366 RoLA Pain management based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 367 RoLA Oncology based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 368 RoLA Solid Tumor based In vivo CRO Market, by Model, 2015 - 2026 (USD Million)
Table 369 RoLA CNS based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 370 RoLA In vivo CRO Market, by GLP Type 2015 - 2026 (USD Million)
Table 371 RoLA GLP Toxicology based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 372 RoLA Non-GLP based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 373 RoLA Rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 374 RoLA Rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 375 RoLA Non-rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 376 RoLA Non-rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 377 MEA In vivo CRO Market Estimates & Forecasts, by Country, 2014 - 2026 (USD Million)
Table 378 MEA In vivo GLP type CRO Market, by Country 2015 - 2026 (USD Million)
Table 379 MEA In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
Table 380 MEA Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 381 MEA Non-rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 382 MEA In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 383 MEA Autoimmune Conditions based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 384 MEA Pain management based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 385 MEA Oncology based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 386 MEA Solid Tumor based In vivo CRO Market, by Model, 2015 - 2026 (USD Million)
Table 387 MEA CNS based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 388 MEA In vivo CRO Market, by GLP Type 2015 - 2026 (USD Million)
Table 389 MEA GLP Toxicology based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 390 MEA Non-GLP based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 391 MEA Rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 392 MEA Rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 393 MEA Non-rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 394 MEA Non-rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 395 South Africa In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
Table 396 South Africa Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 397 South Africa Non-rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 398 South Africa In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 399 South Africa Autoimmune Conditions based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 400 South Africa Pain management based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 401 South Africa Oncology based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 402 South Africa Solid Tumor based In vivo CRO Market, by Model, 2015 - 2026 (USD Million)
Table 403 South Africa CNS based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 404 South Africa In vivo CRO Market, by GLP Type 2015 - 2026 (USD Million)
Table 405 South Africa GLP Toxicology based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 406 South Africa Non-GLP based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 407 South Africa Rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 408 South Africa Rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 409 South Africa Non-rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 410 South Africa Non-rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 411 Saudi Arabia In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
Table 412 Saudi Arabia Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 413 Saudi Arabia Non-rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 414 Saudi Arabia In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 415 Saudi Arabia Autoimmune Conditions based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 416 Saudi Arabia Pain management based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 417 Saudi Arabia Oncology based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 418 Saudi Arabia Solid Tumor based In vivo CRO Market, by Model, 2015 - 2026 (USD Million)
Table 419 Saudi Arabia CNS based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 420 Saudi Arabia In vivo CRO Market, by GLP Type 2015 - 2026 (USD Million)
Table 421 Saudi Arabia GLP Toxicology based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 422 Saudi Arabia Non-GLP based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 423 Saudi Arabia Rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 424 Saudi Arabia Rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 425 Saudi Arabia Non-rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 426 Saudi Arabia Non-rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 427 UAE In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
Table 428 UAE Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 429 UAE Non-rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 430 UAE In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 431 UAE Autoimmune Conditions based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 432 UAE Pain management based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 433 UAE Oncology based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 434 UAE Solid Tumor based In vivo CRO Market, by Model, 2015 - 2026 (USD Million)
Table 435 UAE CNS based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 436 UAE In vivo CRO Market, by GLP Type 2015 - 2026 (USD Million)
Table 437 UAE GLP Toxicology based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 438 UAE Non-GLP based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 439 UAE Rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 440 UAE Rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 441 UAE Non-rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 442 UAE Non-rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 443 RoMEA In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
Table 444 RoMEA Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 445 RoMEA Non-rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
Table 446 RoMEA In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 447 RoMEA Autoimmune Conditions based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 448 RoMEA Pain management based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 449 RoMEA Oncology based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 450 RoMEA Solid Tumor based In vivo CRO Market, by Model, 2015 - 2026 (USD Million)
Table 451 RoMEA CNS based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
Table 452 RoMEA In vivo CRO Market, by GLP Type 2015 - 2026 (USD Million)
Table 453 RoMEA GLP Toxicology based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 454 RoMEA Non-GLP based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
Table 455 RoMEA Rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 456 RoMEA Rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
Table 457 RoMEA Non-rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
Table 458 RoMEA Non-rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)


List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Commodity Flow Analysis
Fig. 9 Volume Price Analysis
Fig. 10 Penetration & growth prospect mapping
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Porter’s five forces analysis
Fig. 14 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 15 In vivo CRO market Type outlook: Key takeaways
Fig. 16 In vivo CRO market: Type movement analysis
Fig. 17 Rodent based In vivo GLP Type market, 2015 - 2026 (USD Billion)
Fig. 18 Rats based In vivo CRO market, 2015 - 2026 (USD Billion)
Fig. 19 Mice based In vivo CRO market, 2015 - 2026 (USD Billion)
Fig. 20 Others market, 2015 - 2026 (USD Billion)
Fig. 21 Non-rodent based In vivo GLP Type market, 2015 - 2026 (USD Billion)
Fig. 22 Hamsters based In vivo CRO market, 2015 - 2026 (USD Billion)
Fig. 23 Guinea pigs based In vivo CRO market, 2015 - 2026 (USD Billion)
Fig. 24 Gerbils based In vivo CRO market, 2015 - 2026 (USD Billion)
Fig. 25 Others based In vivo CRO market, 2015 - 2026 (USD Billion)
Fig. 26 In vivo CRO market Application outlook: Key takeaways
Fig. 27 In vivo CRO market: Type movement analysis
Fig. 28 Non GLP market, 2015 - 2026 (USD Billion)
Fig. 29 In house market, 2015 - 2026 (USD Billion)
Fig. 30 Outsourcing market, 2015 - 2026 (USD Billion)
Fig. 31 GLP toxicology market, 2015 - 2026 (USD Billion)
Fig. 32 In house market, 2015 - 2026 (USD Billion)
Fig. 33 Outsourcing market, 2015 - 2026 (USD Billion)
Fig. 34 In vivo CRO market indication outlook: Key takeaways
Fig. 35 In vivo CRO market: Indication movement analysis
Fig. 36 Autoimmune/ inflammatory conditions market, 2015 - 2026 (USD Billion)
Fig. 37 Rheumatoid arthritis market, 2015 - 2026 (USD Billion)
Fig. 38 Multiple sclerosis market, 2015 - 2026 (USD Billion)
Fig. 39 Osteoarthritis market, 2015 - 2026 (USD Billion)
Fig. 40 Irritable bowel syndrome market, 2015 - 2026 (USD Billion)
Fig. 41 Others market, 2015 - 2026 (USD Billion)
Fig. 42 Pain management market, 2015 - 2026 (USD Billion)
Fig. 43 Chronic pain market, 2015 - 2026 (USD Billion)
Fig. 44 Acute pain market, 2015 - 2026 (USD Billion)
Fig. 45 Oncology market, 2015 - 2026 (USD Billion)
Fig. 46 Blood cancer market, 2015 - 2026 (USD Billion)
Fig. 47 Solid tumor market, 2015 - 2026 (USD Billion)
Fig. 48 Syngeneic model market, 2015 - 2026 (USD Billion)
Fig. 49 Patient derived xenograft market, 2015 - 2026 (USD Billion)
Fig. 50 Xenograft market, 2015 - 2026 (USD Billion)
Fig. 51 Others market, 2015 - 2026 (USD Billion)
Fig. 52 CNS conditions market, 2015 - 2026 (USD Billion)
Fig. 53 Epilepsy market, 2015 - 2026 (USD Billion)
Fig. 54 Parkinson’s disease market, 2015 - 2026 (USD Billion)
Fig. 55 Huntington’s disease market, 2015 - 2026 (USD Billion)
Fig. 56 Stroke market, 2015 - 2026 (USD Billion)
Fig. 57 Traumatic brain injury market, 2015 - 2026 (USD Billion)
Fig. 58 ALS market, 2015 - 2026 (USD Billion)
Fig. 59 Muscle regeneration market, 2015 - 2026 (USD Billion)
Fig. 60 Others market, 2015 - 2026 (USD Billion)
Fig. 61 Diabetes market, 2015 - 2026 (USD Billion)
Fig. 62 Obesity market, 2015 - 2026 (USD Billion)
Fig. 63 Others market, 2015 - 2026 (USD Billion)
Fig. 64 In vivo CRO market: Crisscross matrix
Fig. 65 Non GLP market, 2015 - 2026 (USD Billion)
Fig. 66 GLP toxicology market, 2015 - 2026 (USD Billion)
Fig. 67 Non GLP market, 2015 - 2026 (USD Billion)
Fig. 68 GLP toxicology market, 2015 - 2026 (USD Billion)
Fig. 69 Regional market place: Key takeaways
Fig. 70 Regional outlook, 2017 & 2026
Fig. 71 North America In vivo CRO market, 2015 - 2026 (USD Billion)
Fig. 72 U.S. In vivo CRO market, 2015 - 2026 (USD Billion)
Fig. 73 Canada In vivo CRO market, 2015 - 2026 (USD Billion)
Fig. 74 Europe In vivo CRO market, 2015 - 2026 (USD Billion)
Fig. 75 France In vivo CRO market, 2015 - 2026 (USD Billion)
Fig. 76 U.K. In vivo CRO market, 2015 - 2026 (USD Billion)
Fig. 77 Germany In vivo CRO market, 2015 - 2026 (USD Billion)
Fig. 78 Italy In vivo CRO market, 2015 - 2026 (USD Billion)
Fig. 79 Spain In vivo CRO market, 2015 - 2026 (USD Billion)
Fig. 80 Asia Pacific In vivo CRO market, 2015 - 2026 (USD Billion)
Fig. 81 Japan In vivo CRO market, 2015 - 2026 (USD Billion)
Fig. 82 China In vivo CRO market, 2015 - 2026 (USD Billion)
Fig. 83 India In vivo CRO market, 2015 - 2026 (USD Billion)
Fig. 84 Australia In vivo CRO market, 2015 - 2026 (USD Billion)
Fig. 85 South Korea In vivo CRO market, 2015 - 2026 (USD Billion)
Fig. 86 Latin America In vivo CRO market, 2015 - 2026 (USD Billion)
Fig. 87 Brazil In vivo CRO market, 2015 - 2026 (USD Billion)
Fig. 88 Mexico In vivo CRO market, 2015 - 2026 (USD Billion)
Fig. 89 Argentina In vivo CRO market, 2015 - 2026 (USD Billion)
Fig. 90 Colombia In vivo CRO market, 2015 - 2026 (USD Billion)
Fig. 91 MEA In vivo CRO market, 2015 - 2026 (USD Billion)
Fig. 92 South Africa In vivo CRO market, 2015 - 2026 (USD Billion)
Fig. 93 Saudi Arabia In vivo CRO market, 2015 - 2026 (USD Billion)
Fig. 94 UAE In vivo CRO market, 2015 - 2026 (USD Billion)
Fig. 95 Strategy framework

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.